原发性醛固酮增多症
医学
血浆肾素活性
肾功能
醛固酮
内科学
蛋白尿
泌尿科
肌酐
内分泌学
醛固酮增多症
肾素-血管紧张素系统
原发性高血压
血压
作者
Cristiana Catena,GianLuca Colussi,Elisa Nadalini,Alessandra Chiuch,Sara Baroselli,Roberta Lapenna,Leonardo A. Sechi
出处
期刊:Clinical Journal of The American Society of Nephrology
[American Society of Nephrology]
日期:2007-04-26
卷期号:2 (4): 722-731
被引量:108
摘要
Background: The renal damage that is present in primary aldosteronism might reflect functional and potentially reversible abnormalities that are initiated by glomerular hyperfiltration. The aim of this study was to investigate the relationships of plasma renin and aldosterone concentrations with renal outcomes after treatment of primary aldosteronism. Design, setting, participants, and measurements: Fifty-six consecutive patients who had primary aldosteronism and were recruited in a university center were studied. Patients were prospectively followed after either surgical or medical treatment for a mean of 6.2 yr, during which they received antihypertensive drugs to reach a target BP of <140/90 mmHg. Results: At baseline, patients with primary aldosteronism had higher creatinine clearance and albuminuria than 323 patients with essential hypertension and 113 normotensive individuals. In patients with primary aldosteronism, plasma active renin levels that were higher than the lower limit of detection (2.5 pg/ml) were associated with higher BP, plasma potassium, and albuminuria and lower creatinine clearance. Plasma aldosterone concentrations that were higher than the median value (225 pg/ml) were associated with lower plasma potassium and higher creatinine clearance. Creatinine clearance was correlated directly with plasma aldosterone and inversely with renin. During follow-up, patients with higher baseline plasma renin required use of more antihypertensive drugs to obtain BP control and had a smaller early decline in albuminuria than did patients with suppressed renin. Conclusions: Escape of renin from suppression by excess aldosterone is associated with evidence of more severe renal damage in patients with primary aldosteronism and predicts less favorable outcomes after treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI